嚴重急性呼吸道症候群病毒之B細胞抗原決定位及其胜肽抗原(SARS-COV-SPECIFIC B-CELL EPITOPE AND APPLICATIONS THEREOF )
  ‧ 專利名稱 嚴重急性呼吸道症候群病毒之B細胞抗原決定位及其胜肽抗原(SARS-COV-SPECIFIC B-CELL EPITOPE AND APPLICATIONS THEREOF )
  ‧ 專利證書號 US 7,740,858 B2
  ‧ 專利權人 國立臺灣大學
  ‧ 專利國家
    (申請日)
美國 (2004/09/21)
  ‧ 發明人 吳漢忠, 劉怡如, 邱倩玉,
 
技術摘要:
Disclosed is SARS-CoV-specific B-cell epitope and applications thereof. The epitopes are peptides and can either be expressed in phages or synthesized to diagnose SARS patients accurately. High sensitivity and specificity of the serologic detection are achievable by using a plurality of SARS-CoV-specific B-cell epitope-based peptides. Therefore, the peptides can be applied to SARS diagnosis and have potentials to be immunogens for producing antibodies against SARS.



聯繫方式
聯絡人: 研發處產學合作總中心 電話: (02)3366-9949
地 址: 10087台北市中正區思源街18號 臺大水源校區思源樓3樓